Wuxi Vaccines

Wuxi Vaccines company information, Employees & Contact Information

Explore related pages

Related company profiles:

WuXi Vaccines, a subsidiary of WuXi Biologics, focuses on human vaccine discovery, development and manufacture. An exciting new addition to the WuXi Biologics family, WuXi Vaccines will bring to the global vaccine industry the world-class integrated platforms and CDMO business model on which WuXi Biologics reputation is based. We provide an integrated global CDMO platform for vaccine development and manufacturing for global clients. In Dundalk, Ireland we are constructing a world class integrated vaccine manufacturing facility, which will include drug substance manufacturing (DS), drug product manufacturing (DP), Manufacturing Science and Technology Labs (MS&T) as well as Quality Control labs (QC), dedicated to manufacturing our partner’s vaccine products for the global market.

Company Details

Employees
94
Founded
-
Address
Shanghai, Cn
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Shanghai
Looking for a particular Wuxi Vaccines employee's phone or email?

Wuxi Vaccines Questions

News

WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index - Yahoo Finance

WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index Yahoo Finance

Global CRDMO Leader WuXi Biologics Secures 5th Consecutive FTSE4Good Index Recognition for ESG Excellence - Stock Titan

Global CRDMO Leader WuXi Biologics Secures 5th Consecutive FTSE4Good Index Recognition for ESG Excellence Stock Titan

WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year - The Manila Times

WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year The Manila Times

WuXi Biologics Achieves "CDMO of the Year" Among Three Prestigious IMAPAC Awards - Yahoo Finance

WuXi Biologics Achieves "CDMO of the Year" Among Three Prestigious IMAPAC Awards Yahoo Finance

Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager - Business Wire

Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager Business Wire

WuXi Biologics are Hiring - Operations Excellence (WBS) Lead - Careers Portal

WuXi Biologics are Hiring - Operations Excellence (WBS) Lead Careers Portal

WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi - Yahoo Finance

WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi Yahoo Finance

WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect - PR Newswire

WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect PR Newswire

WuXi Biologics Reports Solid 2025 Interim Results - Yahoo Finance

WuXi Biologics Reports Solid 2025 Interim Results Yahoo Finance

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations - PR Newswire

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations PR Newswire

Record-Breaking 230 mg/mL: WuXi Biologics New Platform Solves Major Biologics Manufacturing Challenge - Stock Titan

Record-Breaking 230 mg/mL: WuXi Biologics New Platform Solves Major Biologics Manufacturing Challenge Stock Titan

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale - PR Newswire

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale PR Newswire

WuXi Biologics Revenue Jumps 10%, Non-COVID Business Surges 13% With Massive $18.5B Backlog - Stock Titan

WuXi Biologics Revenue Jumps 10%, Non-COVID Business Surges 13% With Massive $18.5B Backlog Stock Titan

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership - PR Newswire

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership PR Newswire

WuXi Biologics Honored with 2025 Global Customer Value Leadership Recognition by Frost & Sullivan - Yahoo Finance

WuXi Biologics Honored with 2025 Global Customer Value Leadership Recognition by Frost & Sullivan Yahoo Finance

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication - Yahoo Finance

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication Yahoo Finance

The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development - Yahoo Finance

The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development Yahoo Finance

WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development - Yahoo Finance

WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development Yahoo Finance

WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs - The Korea Herald

WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs The Korea Herald

WuXi Biologics and WuXi XDC Congratulate DualityBio on Entering Global Licensing and Collaboration Agreements with BioNTech to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics - Stock Titan

WuXi Biologics and WuXi XDC Congratulate DualityBio on Entering Global Licensing and Collaboration Agreements with BioNTech to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics Stock Titan

WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu - PR Newswire

WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu PR Newswire

WuXi Biologics Included in S&P Global Sustainability Yearbook 2025 - Lelezard

WuXi Biologics Included in S&P Global Sustainability Yearbook 2025 Lelezard

WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors - BioInformant

WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors BioInformant

WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany - PR Newswire UK

WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany PR Newswire UK

WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai - NAI500

WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai NAI500

WuXi XDC Received Multiple Awards from 2025 Extel (previously "Institutional Investor") Ranking in Diverse Categories - taiwannews.com.tw

WuXi XDC Received Multiple Awards from 2025 Extel (previously "Institutional Investor") Ranking in Diverse Categories taiwannews.com.tw

Chinese biotech firm allots $1.4b for Singapore expansion - Tech in Asia

Chinese biotech firm allots $1.4b for Singapore expansion Tech in Asia

Chinese firms WuXi Biologics, WuXi AppTec investing up to $4b in Singapore - The Straits Times

Chinese firms WuXi Biologics, WuXi AppTec investing up to $4b in Singapore The Straits Times

Top Wuxi Vaccines Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant